The inhibition of the RhoA/ROCK1 pathway by 3-Hydroxy-3-methylglutaryl CoA reductase inhibitor has also been reported to block the HG-induced dysregulation of occludin and ZO-1 and could prevent the onset of albuminuria during the early stage of DN [32]. Here, HMGCR is linked to liver dysplastic nodule.